| Three-dimensional cephalometric analysis of the maxilla: Analysis of new landmarks MD Han, MR Momin, AM Munaretto, S Hao American Journal of Orthodontics and Dentofacial Orthopedics 156 (3), 337-344, 2019 | 15 | 2019 |
| Comparisons of classification methods for viral genomes and protein families using alignment-free vectorization HH Huang, S Hao, S Alarcon, J Yang Statistical Applications in Genetics and Molecular Biology 17 (4), 20180004, 2018 | 7 | 2018 |
| Support point of locally optimal designs for multinomial logistic regression models S Hao, M Yang Journal of Statistical Planning and Inference 209, 144-159, 2020 | 6 | 2020 |
| Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis MEF Mohamed, Y Qian, R D'Cunha, T Sligh, LK Ferris, A Eldred, GF Levy, ... Clinical and Translational Science 17 (1), e13682, 2024 | 2 | 2024 |
| OP0164 SAFETY AND EFFICACY OF UPADACITINIB FOR PEDIATRIC PATIENTS WITH POLYARTICULAR COURSE JUVENILE IDIOPATHIC ARTHRITIS: AN INTERIM ANALYSIS OF AN OPEN-LABEL, PHASE 1 TRIAL H Brunner, G Horneff, I Foeldvari, J Anton, ME Mohamed, Y Qian, ... Annals of the Rheumatic Diseases 82 (Suppl 1), 108-109, 2023 | 2 | 2023 |
| POS0751 PHARMACOKINETICS OF UPADACITINIB IN PEDIATRIC PATIENTS WITH POLYARTICULAR COURSE JUVENILE IDIOPATHIC ARTHRITIS Y Qian, A Shmagel, S Hao, G Horneff, H Brunner, H Camp, W Liu, ... Annals of the Rheumatic Diseases 82 (Suppl 1), 666-667, 2023 | 1 | 2023 |
| Pharmacokinetics, Safety, and Tolerability of Cedirogant in Healthy Japanese and Chinese Adults MEF Mohamed, Y Qian, R D'Cunha, S Hao, R Carcereri De Prati, GF Levy, ... Clinical Pharmacology in Drug Development, 2024 | | 2024 |
| 43882 Pharmacokinetics, Safety, and Efficacy of Cedirogant (ABBV-157) in Patients With Moderate-to-Severe Plaque Psoriasis R D'Cunha, T Sligh, LK Ferris, A Eldred, S Hao, W Liu, S Jazayeri, ... Journal of the American Academy of Dermatology 89 (3), AB206, 2023 | | 2023 |
| 43227 Pharmacokinetics, Safety, and Tolerability of Cedirogant, a RORyt Inverse Agonist, in Healthy Volunteers ME Mohamed, Y Qian, R D’Cunha, S Hao, RC De Prati, W Liu Journal of the American Academy of Dermatology 89 (3), AB207, 2023 | | 2023 |
| Algorithm-Based Optimal and Efficient Exact Experimental Designs for Crossover and Interference Models S Hao, M Yang, W Zheng The New England Journal of Statistics in Data Science 1 (3), 361-370, 2023 | | 2023 |
| Pharm Aco Kin Etics, Safety, and Tolerability of Upadacitinib in Children with Atopic Dermatitis Y Qian, E Raymundo, S Hao, K Unnebrink, J Liu, H Teixeira, A Chu, ... Clinical Pharmacology and Therapeutics, S78-S78, 2023 | | 2023 |
